StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Processa Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Processa Pharmaceuticals's price to book ratio was 2.3× on Jul 31, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.3× to 4.6×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20262.3×+1.2
2025Dec 31, 20251.0×+0.3
2024Dec 31, 20240.8×−0.4
2023Dec 29, 20231.1×+0.1
2022Dec 30, 20221.0×−1.8
2021Dec 31, 20212.8×−4.1
2020Dec 31, 20206.9×−4.5
2019Dec 31, 201911.4×−1.9
2018Dec 31, 201813.3×−279.8
2015Jul 31, 2015293.0×−203.3
2014Oct 31, 2014496.4×–

More Processa Pharmaceuticals figures

See a number that looks wrong?